Forest Labs Falls After Quarterly Loss Exceeds Estimates

Forest Laboratories Inc., the drugmaker that lost patent protection on its top-selling product in March, plunged the most in three months after posting a third-quarter loss wider than analysts’ expectations.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.